慢性肾脏病中他汀类药物的难题。 - Suppr

Suppr

超能文献

The conundrum of statins in chronic kidney disease.

作者信息

Bell S, Deighan C J

机构信息

Renal Unit, Glasgow Royal Infirmary, Castle Street, Glasgow.

出版信息

Scott Med J. 2010 Feb;55(1):30-3. doi: 10.1258/RSMSMJ.55.1.30.

DOI:10.1258/RSMSMJ.55.1.30

PMID:20218278

Abstract

摘要

相似文献

The conundrum of statins in chronic kidney disease.

Scott Med J. 2010 Feb;55(1):30-3. doi: 10.1258/RSMSMJ.55.1.30.

Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?

Am J Kidney Dis. 2005 Mar;45(3):607-9. doi: 10.1053/j.ajkd.2005.01.011.

Statins--beyond lipids in CKD.

Nephrol Dial Transplant. 2011 Feb;26(2):407-10. doi: 10.1093/ndt/gfq662. Epub 2010 Nov 4.

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.

Am J Kidney Dis. 2005 Mar;45(3):473-84. doi: 10.1053/j.ajkd.2004.11.015.

[Chronic kidney disease and statins].

Lijec Vjesn. 2006 Nov-Dec;128(11-12):345-50.

Statins for chronic kidney disease not requiring dialysis.

Nephrology (Carlton). 2015 Apr;20(4):300-1. doi: 10.1111/nep.12434.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Sao Paulo Med J. 2015 Nov-Dec;133(6):541-2. doi: 10.1590/1516-3180.20151336T2.

Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?

Nat Clin Pract Nephrol. 2006 Jul;2(7):378-87. doi: 10.1038/ncpneph0217.

Statins in patients with chronic kidney disease - an attempt at recommendations.

Curr Med Res Opin. 2013 Nov;29(11):1419-22. doi: 10.1185/03007995.2013.833502. Epub 2013 Aug 27.

Lipid abnormalities and cardiovascular risk in renal disease.

J Am Soc Nephrol. 2008 Jun;19(6):1065-70. doi: 10.1681/ASN.2007101128. Epub 2008 Mar 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The conundrum of statins in chronic kidney disease.

Scott Med J. 2010 Feb;55(1):30-3. doi: 10.1258/RSMSMJ.55.1.30.

Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?

Am J Kidney Dis. 2005 Mar;45(3):607-9. doi: 10.1053/j.ajkd.2005.01.011.

Statins--beyond lipids in CKD.

Nephrol Dial Transplant. 2011 Feb;26(2):407-10. doi: 10.1093/ndt/gfq662. Epub 2010 Nov 4.

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.

Am J Kidney Dis. 2005 Mar;45(3):473-84. doi: 10.1053/j.ajkd.2004.11.015.

[Chronic kidney disease and statins].

Lijec Vjesn. 2006 Nov-Dec;128(11-12):345-50.

Statins for chronic kidney disease not requiring dialysis.

Nephrology (Carlton). 2015 Apr;20(4):300-1. doi: 10.1111/nep.12434.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Sao Paulo Med J. 2015 Nov-Dec;133(6):541-2. doi: 10.1590/1516-3180.20151336T2.

Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?

Nat Clin Pract Nephrol. 2006 Jul;2(7):378-87. doi: 10.1038/ncpneph0217.

Statins in patients with chronic kidney disease - an attempt at recommendations.

Curr Med Res Opin. 2013 Nov;29(11):1419-22. doi: 10.1185/03007995.2013.833502. Epub 2013 Aug 27.

Lipid abnormalities and cardiovascular risk in renal disease.

J Am Soc Nephrol. 2008 Jun;19(6):1065-70. doi: 10.1681/ASN.2007101128. Epub 2008 Mar 27.